OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 2
Data from combined, up to 2021-03-17.
| Vaccinated at 2021-03-17 (%) | Vaccinated at 2021-03-17 (n) | Population | Vaccinated at 2021-03-10 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 26.1% | 667,289 | 2,558,906 | 25.9% | 0.2% |
| Sex | Female | 28.1% | 416,143 | 1,481,970 | 27.9% | 0.2% |
| Male | 23.3% | 251,146 | 1,076,936 | 23.2% | 0.1% | |
| Ethnicity | White - British | 25.7% | 370,629 | 1,439,613 | 25.6% | 0.1% |
| White - Irish | 26.3% | 5,502 | 20,923 | 26.1% | 0.2% | |
| White - Any other White background | 24.9% | 13,706 | 54,992 | 24.7% | 0.2% | |
| Mixed - White and Black Caribbean | 31.4% | 1,162 | 3,703 | 30.8% | 0.6% | |
| Mixed - White and Black African | 22.2% | 259 | 1,169 | 22.2% | 0.0% | |
| Mixed - White and Asian | 25.0% | 329 | 1,316 | 24.5% | 0.5% | |
| Mixed - Any other mixed background | 26.2% | 616 | 2,352 | 25.6% | 0.6% | |
| Asian or Asian British - Indian | 24.6% | 8,071 | 32,753 | 24.4% | 0.3% | |
| Asian or Asian British - Pakistani | 33.9% | 5,670 | 16,723 | 33.0% | 0.9% | |
| Asian or Asian British - Bangladeshi | 35.6% | 1,736 | 4,879 | 34.9% | 0.7% | |
| Asian or Asian British - Any other Asian background | 25.4% | 2,947 | 11,599 | 25.0% | 0.4% | |
| Black or Black British - Caribbean | 32.1% | 7,497 | 23,387 | 31.3% | 0.7% | |
| Black or Black British - African | 27.2% | 2,345 | 8,617 | 26.4% | 0.8% | |
| Black or Black British - Any other Black background | 29.1% | 728 | 2,506 | 28.2% | 0.8% | |
| Other ethnic groups - Chinese | 24.3% | 994 | 4,095 | 24.1% | 0.2% | |
| Other ethnic groups - Any other ethnic group | 29.9% | 2,044 | 6,832 | 29.4% | 0.5% | |
| Patients with any other ethnicity code | 25.2% | 99,799 | 395,654 | 25.1% | 0.2% | |
| Ethnicity not stated | 29.2% | 4,830 | 16,513 | 29.1% | 0.2% | |
| Ethnicity not recorded | 27.1% | 138,341 | 511,182 | 26.9% | 0.2% | |
| Ethnicity (broad categories) | White | 25.7% | 389,858 | 1,515,535 | 25.6% | 0.1% |
| Mixed | 27.7% | 2,373 | 8,554 | 27.3% | 0.4% | |
| South Asian | 27.9% | 18,438 | 65,975 | 27.5% | 0.5% | |
| Black | 30.7% | 10,584 | 34,517 | 29.9% | 0.8% | |
| Other | 27.8% | 3,045 | 10,934 | 27.5% | 0.4% | |
| Unknown | 26.3% | 242,977 | 923,363 | 26.1% | 0.2% | |
| Index of Multiple Deprivation | 1 (most deprived) | 29.5% | 100,450 | 340,928 | 29.2% | 0.3% |
| 2 | 27.1% | 117,558 | 433,622 | 26.9% | 0.2% | |
| 3 | 26.2% | 141,995 | 541,737 | 26.0% | 0.2% | |
| 4 | 25.2% | 148,603 | 588,546 | 25.1% | 0.1% | |
| 5 (least deprived) | 24.3% | 153,853 | 634,340 | 24.1% | 0.1% | |
| Unknown | 24.4% | 4,802 | 19,691 | 24.2% | 0.2% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 27.0% | 498,645 | 1,846,677 | 26.8% | 0.2% |
| Patients with Immunosuppression | 25.5% | 28,280 | 110,999 | 25.3% | 0.2% | |
| Patients with CKD | 27.6% | 216,300 | 782,705 | 27.5% | 0.2% | |
| Patients who have Chronic Respiratory Disease | 26.9% | 82,572 | 306,810 | 26.7% | 0.2% | |
| Patients with Diabetes | 27.4% | 142,415 | 519,862 | 27.2% | 0.2% | |
| Patients with Chronic Liver disease | 26.3% | 12,285 | 46,746 | 26.1% | 0.2% | |
| Patients with CNS Disease (including Stroke/TIA) | 31.5% | 135,051 | 428,400 | 31.3% | 0.2% | |
| Patients with Chronic heart disease | 27.3% | 295,890 | 1,084,643 | 27.1% | 0.2% | |
| Patients with Asplenia or Dysfunction of the Spleen | 24.7% | 5,096 | 20,615 | 24.6% | 0.1% | |
| Patients with Wider Learning Disability | 46.8% | 609 | 1,302 | 46.2% | 0.5% | |
| Patients with Severe Mental Health | 38.0% | 6,608 | 17,409 | 37.6% | 0.4% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 30.3% | 229,033 | 754,789 | 30.1% | 0.2% |
| Patients with Morbid Obesity | 34.9% | 12,208 | 35,014 | 34.6% | 0.3% | |
| Patients who are pregnant | 26.7% | 84 | 315 | 26.7% | 0.0% |